252 related articles for article (PubMed ID: 18461366)
1. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
Xu G; Zhang J
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
[TBL] [Abstract][Full Text] [Related]
2. Suppression of FasL expression in tumor cells and preventing tumor necrosis factor-induced apoptosis by adenovirus 14.7K is an effective escape mechanism for immune cells.
Zhang J; Xu G
Cancer Genet Cytogenet; 2007 Dec; 179(2):112-7. PubMed ID: 18036397
[TBL] [Abstract][Full Text] [Related]
3. [Immune evasion of human lung carcinoma cell A549 suppressed by human lymphoma cell Jurkat via Fas/FasL pathway].
Wang H; Zhang G; Dai J; Min J
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):681-5. PubMed ID: 20673483
[TBL] [Abstract][Full Text] [Related]
4. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
Kassouf N; Thornhill MH
Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
[TBL] [Abstract][Full Text] [Related]
5. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.
Dotti G; Savoldo B; Pule M; Straathof KC; Biagi E; Yvon E; Vigouroux S; Brenner MK; Rooney CM
Blood; 2005 Jun; 105(12):4677-84. PubMed ID: 15713795
[TBL] [Abstract][Full Text] [Related]
8. [Apoptosis of active T lymphocytes induced by human laryngocarcinoma cell line].
Ye J; Zhang G; Liu X; Yang Q; Li P; Huang J; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jun; 22(12):560-3. PubMed ID: 18800686
[TBL] [Abstract][Full Text] [Related]
9. CpG oligonucleotides suppress HepG2 cells-induced Jurkat cell apoptosis via the Fas-FasL-mediated pathway.
Zheng J; Fu R; Li J; Wang X
J Exp Clin Cancer Res; 2011 May; 30(1):48. PubMed ID: 21535900
[TBL] [Abstract][Full Text] [Related]
10. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.
Xu T; Sun BC; Li Q; Hao XS
World J Gastroenterol; 2005 Jul; 11(25):3915-9. PubMed ID: 15991293
[TBL] [Abstract][Full Text] [Related]
11. Effects of specific antisense oligonucleotide inhibition of Fas expression on T cell apoptosis induced by Fas ligand.
Mao H; Liu Q; Zhang J; Gu H; Wang L; Zhou X; Yin H; Zhang L; Xie F; Jiang G
Int Immunopharmacol; 2007 Dec; 7(13):1714-22. PubMed ID: 17996681
[TBL] [Abstract][Full Text] [Related]
12. Activated T cell exosomes promote tumor invasion via Fas signaling pathway.
Cai Z; Yang F; Yu L; Yu Z; Jiang L; Wang Q; Yang Y; Wang L; Cao X; Wang J
J Immunol; 2012 Jun; 188(12):5954-61. PubMed ID: 22573809
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells.
Li MS; Ma QL; Chen Q; Liu XH; Li PF; Du GG; Li G
World J Gastroenterol; 2005 May; 11(17):2564-9. PubMed ID: 15849812
[TBL] [Abstract][Full Text] [Related]
14. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1-regulated Fas/FasL pathway activation suppresses nucleus pulposus cell apoptosis in an inflammatory environment.
Xie J; Li B; Yao B; Zhang P; Wang L; Lu H; Song X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31808511
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D delays Fas- and TRAIL-mediated extrinsic pathway of apoptosis in T cells.
Djiadeu P; Kotra LP; Sweezey N; Palaniyar N
Apoptosis; 2017 May; 22(5):730-740. PubMed ID: 28168327
[TBL] [Abstract][Full Text] [Related]
17. Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
Martínez-Lorenzo MJ; Alava MA; Gamen S; Kim KJ; Chuntharapai A; Piñeiro A; Naval J; Anel A
Eur J Immunol; 1998 Sep; 28(9):2714-25. PubMed ID: 9754559
[TBL] [Abstract][Full Text] [Related]
18. Induction of FAS ligand expression in a human hepatoblastoma cell line by HCV core protein.
Ruggieri A; Murdolo M; Rapicetta M
Virus Res; 2003 Nov; 97(2):103-10. PubMed ID: 14602201
[TBL] [Abstract][Full Text] [Related]
19. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
